Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Trial to Evaluate the Safety Performance and Initial Efficacy of a Guided Bone Regeneration Membrane for the Treatment of Proximal (Subtrochanteric) Femoral Fractures

NCT01687530 is registered in ClinicalTrials.gov with RegeneCure, Ltd. as lead sponsor.

NCT NCT01687530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01687530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Trial to Evaluate the Safety Performance and Initial Efficacy of a Guided Bone Regeneration Membrane for the Treatment of Proximal (Subtrochanteric) Femoral Fractures
Lead sponsor
RegeneCure, Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
48 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

distal femoral fractures, proximal (subtrochanteric)femoral fractures